Concepedia

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Yin Chen, Jin Zhong, Hongxing Pan, Fengjuan Shi,

The Lancet Respiratory Medicine · 2022 · 170 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas, Nell Saunders, Piet Maes et al. · Nature · 2021 · 1.6K citations · Full text

, , +14

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.5K citations · Full text

, , +17

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

, , +17

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng, Daniel J. Phillips, Thomas White et al. · Nature Medicine · 2021 · 1.2K citations · Full text

, , +17

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar‐On, Yair Goldberg, Micha Mandel et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

, , +17